{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:00:30Z","timestamp":1793023230550,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.ejpn.2012.12.008","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T01:45:34Z","timestamp":1360028734000},"page":"348-352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations"],"prefix":"10.1016","volume":"17","author":[{"given":"Sergiusz","family":"J\u00f3\u017awiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Nabbout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Curatolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9639","key":"10.1016\/j.ejpn.2012.12.008_bib1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejpn.2012.12.008_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-4632.2010.04727.x","article-title":"Tuberous sclerosis complex: tumors and tumorigenesis","volume":"50","author":"Borkowska","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ejpn.2012.12.008_bib3","first-page":"315","article-title":"Surgical timing of the subependymal giant cell astrocytoma (SEGA) with the patients of tuberous sclerosis complex","volume":"21","author":"Ekici","year":"2011","journal-title":"Turk Neurosurg"},{"key":"10.1016\/j.ejpn.2012.12.008_bib4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/jnnp.66.3.370","article-title":"Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis","volume":"66","author":"Nabbout","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ejpn.2012.12.008_bib5","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1212\/01.WNL.0000142039.14522.1A","article-title":"Subependymal giant cell tumors in tuberous sclerosis complex","volume":"63","author":"Goh","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2012.12.008_bib6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/sj.ejhg.5201625","article-title":"Tuberous sclerosis","volume":"14","author":"Yates","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ejpn.2012.12.008_bib7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-1331.2009.02567.x","article-title":"Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature","volume":"16","author":"Adriaensen","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ejpn.2012.12.008_bib8","first-page":"39","article-title":"Subependymal giant cell astrocytomas with atypical histological features mimicking malignant gliomas","volume":"49","author":"Grajkowska","year":"2011","journal-title":"Folia Neuropathol"},{"key":"10.1016\/j.ejpn.2012.12.008_bib9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s11940-011-0123-z","article-title":"Subependymal giant cell astrocytoma (SEGA) treatment update","volume":"13","author":"Campen","year":"2011","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.ejpn.2012.12.008_bib10","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00381-011-1406-0","article-title":"The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective","volume":"27","author":"Moavero","year":"2011","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.ejpn.2012.12.008_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00381-010-1159-1","article-title":"The diagnosis and treatment of subependymal giant cell astrocytoma combined with tuberous sclerosis","volume":"27","author":"Jiang","year":"2011","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.ejpn.2012.12.008_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12519-010-0025-2","article-title":"Management of subependymal giant cell tumors in tuberous sclerosis complex: the neurosurgeon's perspective","volume":"6","author":"Berhouma","year":"2010","journal-title":"World J Pediatr"},{"key":"10.1016\/j.ejpn.2012.12.008_bib13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1185\/03007995.2012.658907","article-title":"Outcomes of resecting subependymal giant cell astrocytoma (SEGA) among patients with SEGA-related tuberous sclerosis complex: a national claims database analysis","volume":"28","author":"Sun","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ejpn.2012.12.008_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1227\/01.NEU.0000249216.19591.5D","article-title":"Subependymal giant-cell astrocytomas in pediatric tuberous sclerosis disease: when should we operate?","volume":"60","author":"de Ribaupierre","year":"2007","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ejpn.2012.12.008_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.18632\/aging.100298","article-title":"Potential of mTOR inhibitors for the treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex","volume":"3","author":"Major","year":"2011","journal-title":"Aging"},{"key":"10.1016\/j.ejpn.2012.12.008_bib16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ejpn.2012.12.008_bib17","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejpn.2012.12.008_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejpn.2011.09.006","article-title":"Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex","volume":"16","author":"Perek-Polnik","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ejpn.2012.12.008_bib19","first-page":"5645","article-title":"Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors","volume":"62","author":"Kenerson","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejpn.2012.12.008_bib20","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1073\/pnas.202476899","article-title":"Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling","volume":"99","author":"Tee","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejpn.2012.12.008_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1749-6632.2009.05117.x","article-title":"The tuberous sclerosis complex","volume":"1184","author":"Orlova","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ejpn.2012.12.008_bib22","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/jnen\/63.12.1236","article-title":"Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation","volume":"63","author":"Chan","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.ejpn.2012.12.008_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/08830738040190020401","article-title":"Tuberin and hamartin expression is reduced in the majority of subependymal giant cell astrocytomas in tuberous sclerosis complex consistent with a two-hit model of pathogenesis","volume":"19","author":"J\u00f3\u017awiak","year":"2004","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejpn.2012.12.008_bib24","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2176\/nmc.43.616","article-title":"Subependymal giant cell astrocytoma with positive tuberin expression\u2013case report","volume":"43","author":"Tabuchi","year":"2003","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.ejpn.2012.12.008_bib25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1468-1331.1996.tb00431.x","article-title":"Occlusive hydrocephalus complicating tuberous sclerosis: report of two cases","volume":"3","author":"B\u00fcki","year":"1996","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ejpn.2012.12.008_bib26","first-page":"1321","article-title":"Immunohistochemical and microscopic studies on giant cells in tuberous sclerosis","volume":"20","author":"Jozwiak","year":"2005","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.ejpn.2012.12.008_bib27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000325550","article-title":"Cytologic features of subependymal giant cell astrocytom: a review of 7 cases","volume":"52","author":"Takei","year":"2008","journal-title":"Acta Cytol"},{"key":"10.1016\/j.ejpn.2012.12.008_bib28","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/088307389801301206","article-title":"Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria","volume":"13","author":"Roach","year":"1998","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejpn.2012.12.008_bib29","unstructured":"Votubia (everolimus). Summary of product characteristics. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002311\/WC500112238.pdf."},{"key":"10.1016\/j.ejpn.2012.12.008_bib30","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3171\/2010.9.JNS10816","article-title":"Gamma knife surgery for subependymal giant cell astrocytomas. Clinical article","volume":"114","author":"Park","year":"2011","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejpn.2012.12.008_bib31","unstructured":"Krueger DA, et\u00a0al. Long-term safety and efficacy results from an extension phase of an open-label, prospective, phase 1\/2 trial of everolimus in patients with subependymal giant cell astrocytomas in tuberous sclerosis complex. In: Presented at the international TSC research conference. Washington DC; July 2011."},{"issue":"9861","key":"10.1016\/j.ejpn.2012.12.008_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ejpn.2012.12.008_bib33","article-title":"Everolimus for tumor recurrence after surgical resection for subependymal giant cell astrocytoma associated with tuberous sclerosis complex","author":"Franz","year":"2012","journal-title":"J Child Neurol"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379812002644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379812002644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T03:30:31Z","timestamp":1562643031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379812002644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1090379812002644"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2012.12.008","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2012.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}